Related Experiment Videos
Interaction between DNA and some congeners of tilorone
Il Farmaco; Edizione Scientifica
|September 1, 1979
Summary
Tilorone analogs bind to DNA via intercalation, with binding affinity influenced by molecular size and ionic strength. These compounds also inhibit DNA and RNA synthesis in tumor cells, suggesting a link between DNA complexation and biological activity.
Area of Science:
- Molecular Biology
- Medicinal Chemistry
Background:
- Tilorone is a known DNA complexing agent.
- Understanding structure-activity relationships of tilorone analogs is crucial for drug development.
Purpose of the Study:
- To investigate the DNA complex formation ability of tilorone analogs.
- To correlate DNA binding with the inhibition of nucleic acid synthesis.
Main Methods:
- Complex formation was studied using association constants and saturation values (r).
- DNA binding mode was determined by flow dichroism measurements.
- Inhibition of DNA and RNA synthesis was assessed in Ehrlich ascites tumor cells.
Main Results:
- Compounds showed similar association constants but increased saturation values with larger planar moieties or longer side chains.
- Flow dichroism confirmed an intercalative binding mode.
- Decreasing ionic strength enhanced drug-DNA affinity, indicating electrostatic interactions.
- Compounds inhibited DNA and RNA synthesis in tumor cells.
Conclusions:
- The size of the planar moiety and side chain length influence the extent of tilorone analog binding to DNA.
- Electrostatic forces play a significant role in the drug-DNA interaction, particularly at low ionic strength.
- A correlation exists between the DNA complexing ability of these compounds and their inhibitory effect on nucleic acid synthesis, suggesting potential therapeutic applications.